| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
| Ausblick | ||||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 67.90 |
| Vanguard Health Care Fund | 2.99 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 8’400 | 8’600 | 8’600 | 8’700 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.00 | 0.19 | 0.20 | 0.21 | 0.21 |
Bilanz (in Mio. EUR) - Aktiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 1’164 | 1’310 | 1’395 | 1’406 | 1’546 |
| Summe Anlagevermögen | 1’694 | 1’823 | 2’115 | 2’244 | 2’436 |
| Summe Aktiva | 2’505 | 2’746 | 2’967 | 3’025 | 3’228 |
Bilanz (in Mio. EUR) - Passiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 574 | 500 | 517 | 682 | 625 |
| Summe Fremdkapital | 1’375 | 1’413 | 1’360 | 1’454 | 1’406 |
| Summe Eigenkapital | 1’130 | 1’332 | 1’607 | 1’571 | 1’821 |
| Summe Passiva | 2’505 | 2’746 | 2’967 | 3’025 | 3’228 |
Adresse
| 1 New Burlington Place, W1S 2HR London | |
| Telefon | +44 (20) 7399-2760 |
| Fax | +44 (20) 7399-2761 |
| URL | http://www.hikma.com |
Management
|
Bassam Wael Rushdi Kanaan
Executive Vice President-Corporate Development |
|
Cynthia L. Flowers
Independent Non-Executive Director |
|
Douglas Malcolm Hurt
Independent Non-Executive Director |
|
Henriette Nielsen
Executive Vice President-Business Operations |
|
Hussein Arkhagha
Secretary & Chief Counsel |
|
John J. Castellani
Independent Non-Executive Director |
|
Khalid Walid Hosni Nabilsi
Chief Financial Officer |
|
Kristy Ronco
Executive VP-Sales & Marketing |
|
Majda Labadi
Executive VP-Organizational Development |
|
Mary Regina Henderson
Independent Non-Executive Director |
|
Mazen Samih Taleb Darwazah
Executive Vice Chairman & President-MENA Region |
|
Mohammed Ali Khaldoun Al-Husry
Non-Executive Director |
|
Patrick Noel Butler
Senior Independent Non-Executive Director |
|
Riad Mishlawi
President-Injectables Division |
|
Said Samih Taleb Darwazah
Executive Chairman & Chief Executive Officer |
|
Shahin Fesharaki
Chief Scientific Officer |
|
Sigurdur Oli Olafsson
Executive Director |
|
Susan Ringdal
Executive VP-Strategic Planning & Global Affairs |